STOCK TITAN

Teladoc (TDOC) director Jacobson gains 30,441 RSUs and 28,986 shares via RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health director Catherine Jacobson reported routine equity compensation activity. On May 21, 2026 she received a grant of 30,441 restricted stock units, each representing one share of Teladoc common stock, vesting in full on the earlier of May 21, 2027 or the day before the 2027 annual meeting of stockholders.

On May 20, 2026 she also exercised 28,986 previously granted restricted stock units that vested in full on May 20, 2026, converting them into the same number of common shares. Following these transactions, she holds 66,853 Teladoc common shares directly and 30,441 restricted stock units.

Positive

  • None.

Negative

  • None.
Insider Jacobson Catherine
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Units 30,441 $0.00 --
Exercise Restricted Stock Units 28,986 $0.00 --
Exercise Common Stock 28,986 $0.00 --
Holdings After Transaction: Restricted Stock Units — 30,441 shares (Direct, null); Common Stock — 66,853 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders.
New RSU grant 30,441 restricted stock units Granted May 21, 2026 to director Catherine Jacobson
RSU exercise 28,986 restricted stock units Exercised into common stock on May 20, 2026
Shares held after transactions 66,853 common shares Direct holdings following May 20, 2026 exercise
Outstanding RSUs after grant 30,441 restricted stock units Remain subject to vesting after May 21, 2026 grant
Prior RSU award 28,986 restricted stock units Granted May 22, 2025; vested May 20, 2026
Vesting date for new RSUs May 21, 2027 Or the day before the 2027 annual meeting, whichever is earlier
Restricted Stock Units financial
"Restricted Stock Units convert to shares of TDOC common stock on a one-for-one basis."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security is the transaction code description for the RSU conversion."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of TDOC common stock."
vest in full financial
"The restricted stock units vest in full on the earlier of May 21, 2027 and the day immediately preceding the issuer's 2027 annual meeting."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jacobson Catherine

(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, FLOOR 17

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026M28,986A(1)66,853D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/20/2026M28,986 (2) (2)Common Stock28,986$00D
Restricted Stock Units(3)05/21/2026A30,441 (4) (4)Common Stock30,441$030,441D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026.
3. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
4. The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Teladoc (TDOC) director Catherine Jacobson report?

Catherine Jacobson reported a grant of 30,441 restricted stock units on May 21, 2026 and the exercise of 28,986 restricted stock units into common shares on May 20, 2026, both as part of her equity compensation.

How many Teladoc (TDOC) restricted stock units were granted to Catherine Jacobson?

She was granted 30,441 restricted stock units on May 21, 2026. Each unit represents a contingent right to receive one share of Teladoc common stock, vesting in full on the earlier of May 21, 2027 or the day before the 2027 annual meeting.

When do Catherine Jacobson’s new Teladoc (TDOC) restricted stock units vest?

The 30,441 restricted stock units granted to Catherine Jacobson vest in full on the earlier of May 21, 2027 or the day immediately preceding Teladoc’s 2027 annual meeting of stockholders, according to the Form 4 footnote disclosure.

What RSU award did Catherine Jacobson exercise into Teladoc (TDOC) common stock?

She exercised 28,986 restricted stock units that were granted on May 22, 2025 and vested in full on May 20, 2026, converting them into 28,986 shares of Teladoc common stock at a stated price of $0.00 per share.

How many Teladoc (TDOC) common shares does Catherine Jacobson own after these transactions?

After exercising 28,986 restricted stock units into common stock, Catherine Jacobson directly holds 66,853 Teladoc common shares. She also holds 30,441 restricted stock units that remain outstanding and subject to future vesting conditions.

Were there any Teladoc (TDOC) stock sales reported by Catherine Jacobson in this Form 4?

No stock sales were reported. The Form 4 shows only equity compensation activity: a grant of 30,441 restricted stock units and the exercise of 28,986 restricted stock units into common shares, with no dispositions or open-market sales disclosed.